- Incannex Healthcare press release (NASDAQ:IXHL): Q3 GAAP EPS of -$0.84.
- Revenue of $0.08M.
- Research and Development (R&D) expenses for the three months ended March 31, 2025 totaled $2.74 million USD, compared to $3.28 million USD for the same period in 2024.